Vape 10-Q20 May 142014 Q2 Quarterly reportFinancial data

Company Profile

Document_and_Entity_Informatio

Document and Entity Information	6 Months Ended
Document and Entity Information	Mar. 31, 2014	20-May-14
Document And Entity Information [Abstract]	'	'
Entity Registrant Name	'Vape Holdings, Inc.	'
Entity Central Index Key	'0001455819	'
Amendment Flag	'false	'
Current Fiscal Year End Date	'--09-30	'
Document Type	'10-Q	'
Document Period End Date	31-Mar-14	'
Document Fiscal Period Focus	'Q2	'
Document Fiscal Year Focus	'2014	'
Entity Filer Category	'Smaller Reporting Company	'
Entity Common Stock, Shares Outstanding	'	8,612,006

Consolidated_Balance_Sheets_Un

Consolidated Balance Sheets (Unaudited) (USD $)	Mar. 31, 2014	Sep. 30, 2013
Current assets:	'	'
Cash	$598,953	$568
Accounts receivable	5,745	'
Inventory	30,004	'
Other current assets	134,181	'
Total current assets	768,883	568
Property, plant, and equipment, net of accumulated depreciation	42,989	'
TOTAL ASSETS	811,872	568
Current liabilities:	'	'
Accounts payable	216,519	60,346
Accrued expenses	20,051	7,573
Convertible notes payable, net of unamortized discount of $288,681 at March 31, 2014	239,319	'
Related party convertible notes payable, net of unamortized discount of $9,167 at March 31, 2014	40,833	'
Related party notes payable	40,000	234,824
Total current liabilities	556,722	302,743
Long term liabilities:	'	'
Convertible notes payable, long-term, net of unamortized discount of $7,333 at March 31, 2014	26,821	'
Related party convertible notes payable, long-term, net of unamortized discount of $50,723 at March 31, 2014	137,717	'
Related party notes payable, long-term	340,287	'
Accounts payable - related party	'	15,000
Warrant liability	29,430,022	'
Total liabilities	30,491,569	317,743
Commitments and contingencies	'	'
Stockholders' deficit:	'	'
Preferred stock, $0.00001 par value - authorized 100,000,000 shares; 500,000 shares committed at March 31, 2014	'	'
Common stock, $0.00001 par value - authorized 1,000,000,000 shares; 6,559,169 and 6,250,000 issued and outstanding, respectively	66	62
Additional paid-in capital	710,165	'
Accumulated deficit	-30,389,928	-317,237
Total stockholders' deficit	-29,679,697	-317,191
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	$811,872	$568

Consolidated_Balance_Sheets_Pa

Consolidated Balance Sheets (Parenthetical) (USD $)	Mar. 31, 2014	Sep. 30, 2013
Balance Sheets [Abstract]	'	'
Unamortized discount Convertible notes payable,current	$288,681	'
Unamortized discount Related party convertible notes payable, current	9,167	'
Unamortized discount convertible notes payable, non current	7,333	'
Unamortized discount Related party convertible notes payable, non current	$50,723	'
Preferred stock, par value	$0.00	$0.00
Preferred stock, Shares authorized	100,000,000	100,000,000
Preferred stock shares committed	500,000	500,000
Common stock, par value	$0.00	$0.00
Common stock, shares authorized	1,000,000,000	1,000,000,000
Common stock, shares issued	6,559,169	6,250,000
Common stock, shares outstanding	6,559,169	6,250,000

Consolidated_Statements_of_Ope

Consolidated Statements of Operations (Unaudited) (USD $)	3 Months Ended	6 Months Ended
Consolidated Statements of Operations (Unaudited) (USD $)	Mar. 31, 2014	Mar. 31, 2014
Statements of Operations [Abstract]	'	'
Revenue	$30,759	$30,759
Cost of revenue	9,621	9,621
Gross Profit	21,138	21,138
Operating expense:	'	'
Research and development	29,087	37,587
General and administrative	207,851	418,170
Total operating expenses	236,938	455,757
Operating loss	-215,800	-434,619
Other expense:	'	'
Interest expense	51,659	51,659
Interest expense - related party	9,061	57,569
Loss on settlement of warrants	29,528,844	29,528,844
Total other expense	29,589,564	29,638,072
Loss before provision for income taxes	-29,805,364	-30,072,691
Provision for income taxes	'	'
Net loss	($29,805,364)	($30,072,691)
Weighted average shares basic and diluted	6,278,464	6,415,512
Weighted average basic and diluted loss per common share	($4.75)	($4.69)

Consolidated_Statements_of_Sto

Consolidated Statements of Stockholders' Deficit (Unaudited) (USD $)	Total	Series A Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Deficit [Member]
Balance at Sep. 30, 2013	($317,191)	'	$46	'	($317,237)
Balance, Shares at Sep. 30, 2013	'	'	4,684,537	'	'
Shares retained by PeopleString shareholders upon merger	16	'	16	'	'
Shares retained by PeopleString shareholders upon merger, Shares	'	'	1,565,463	'	'
Conversion of related party note payable	64,951	'	4	64,947	'
Conversion of related party note payable, Shares	'	'	275,627	'	'
Fair value of officer services	15,000	'	'	15,000	'
Common stock issued for services	-102,000	'	'	102,000	'
Common stock issued for services, shares	'	'	30,000	'	'
Discount on convertible note payable at 10%	84,375	'	'	84,375	'
Discount on convertible notes payable at 8%	166,400	'	'	166,400	'
Discount on convertible note payable at 6%	92,000	'	'	92,000	'
Discount on related party convertible note payable at 8%	86,621	'	'	86,621	'
Common stock issued in connection with warrant settlement	98,822	'	'	98,822	'
Common stock issued in connection with warrant settlement, Shares	'	'	3,542	'	'
Commitment of preferred stock for HIVE asset acquisition, shares	'	500,000	'	'	'
Net loss	-30,072,691	'	'	'	-30,072,691
Balance at Mar. 31, 2014	($29,679,697)	'	$66	$710,165	($30,389,928)
Balance, Shares at Mar. 31, 2014	'	500,000	6,559,169	'	'

Consolidated_Statements_of_Sto1

Consolidated Statements of Stockholders' Deficit (Parenthetical)	6 Months Ended
	Mar. 31, 2014
Statement of Stockholders' Equity [Abstract]	'
Discount on convertible note payable percentage, one	10.00%
Discount on convertible note payable percentage, two	8.00%
Discount on convertible note payable percentage, three	6.00%
Discount on related party convertible note payable	8.00%

Consolidated_Statements_of_Cas

Consolidated Statements of Cash Flows (Unaudited) (USD $)	6 Months Ended
Consolidated Statements of Cash Flows (Unaudited) (USD $)	Mar. 31, 2014
Cash flows from operating activities:	'
Net loss	($30,072,691)
Adjustments to reconcile net loss to net cash used in operating activities:	'
Fair value of officer services	15,000
Common stock issues for services	102,000
Accretion of debt discount	175,856
Loss on settlement of warrants	29,528,844
Changes in operating assets and liabilities:	'
Accounts receivable	-5,745
Inventory	-30,004
Other current assets	-134,181
Accounts payable	156,173
Accrued expenses	12,478
Net cash used in operating activities	-252,270
Cash flows from investing activities:	'
Capital expenditures	-42,989
Net cash used in investing activities	-42,989
Cash flows from financing activities:	'
Proceeds from issuances of convertible notes payable	448,000
Proceeds from issuances of related party notes payable	340,287
Proceeds from issuances of related party convertible notes payable	242,593
Net repayments to related parties	-137,236
Net cash provided by financing activities	893,644
Net change in cash	598,385
Cash, beginning of period	568
Cash, end of period	598,953
Cash paid during the period for:	'
Interest	'
Taxes	'
Non-cash investing and financing activities:	'
Conversion of related party notes payable	64,951
Issuance of convertible note payable for services	100,000
Issuance of convertible note payable for former officer services	50,000
Issuance of common stock in connection with warrant settlement	$98,822

Description_of_Business_Recent

Description of Business, Recent Acquisitions and Summary of Significant Accounting Policies	6 Months Ended
	Mar. 31, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'
DESCRIPTION OF BUSINESS, RECENT ACQUISITIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	'
	NOTE 1. DESCRIPTION OF BUSINESS, RECENT ACQUISITIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

	BUSINESS

	Vape Holdings, Inc. (formerly PeopleString Corporation) (“Vape,” the “Company,” “we,” “us,” “our,” “our company”) is a holding company with its primary focus in the manufacturing and distribution of healthy and sustainable vaporization products. The Company has designed and recently began marketing and distributing vaporization products under a unique brand. The Company has introduced a nonporous, non-corrosive, chemically inert ceramic vaporization element as a healthy, sustainable alternative to traditional titanium and quartz vaporization materials, as well as lower-grade ceramic found in traditional electronic cigarettes and vaporizers. This material can be used for a wide range of applications, including stand-alone vaporization products and "E-cigs." Electronic cigarettes come in a variety of designs ranging from those that look vastly like traditional cigarettes, to larger vaporizer units which are capable of vaporizing liquid with varying viscosity. The process of vaporization is believed to eliminate the smoke, tar, ash, and other byproducts of traditional smoking by utilizing lower temperatures in a controlled electronic environment.

	HIVE Ceramics is the premier brand under the Vape umbrella, bringing to market a medical and food grade ceramic that has countless design and product crossover capabilities in existing and emerging markets.

	The Company intends to rely on a combination of trademark, copyright, trade secret and patent laws in the United States as well as confidentiality procedures and contractual provisions to protect future proprietary technology and its brands, as they are developed. The Company has created or acquired and continues in the process of creating and/or acquiring proprietary vaporizers and e-cigarettes, and various trademarks, patents and copyrights for brands which are developed or in development. The Company is actively engaged in improving and expanding lines of branded products through business alliances and acquisitions, as well as developing its branded retail business expansion. Vape and its business units are organized and directed to operate strictly in accordance with all applicable state and federal laws.

	RECENT ACQUISITIONS

	On September 30, 2013, the then PeopleString Corporation, and its wholly-owned subsidiary, RewardString Corporation (“RewardString”), and Vape Holdings, Inc., a Nevada corporation (the “Private Company”) formed on March 26, 2013, closed a Merger and Reorganization Agreement whereby the Private Company merged with RewardString, with the Private Company being the surviving entity (the “Merger”). The Private Company shareholders represented approximately 74.95% of the total issued and outstanding common stock of the merged company.
	The merger among PeopleString, RewardString and the Private Company was accounted for as a reverse acquisition and change in reporting entity, whereby the Private Company was the accounting acquirer. The Merger was accounted for using the purchase method of accounting in accordance with ASC 805 Business Combinations, whereby the estimated purchase was allocated to tangible net assets acquired based upon preliminary fair values at the date of acquisition. Accordingly, the assets and liabilities of PeopleString and RewardString were recorded at fair value; the assets of PeopleString and RewardString were not significant. The historical results of operations and cash flows of the Private Company were reported since its inception on March 26, 2013 (“Inception”). On September 30, 2013, the Company approved a change in fiscal year end of the Company from December 31st to September 30th due to a change in reporting entity. Following such change, the date of the Company’s next fiscal year end is September 30, 2014.

	Vape commenced revenue generating operations and exited the development stage late in the three month period ended March 31, 2014. There was no significant activity during the prior period from March 26, 2013 to March 31, 2013 and thus, such periods are not presented.

	Effective as of January 8, 2014, the Company amended its Certificate of Incorporation with the Delaware Secretary of State pursuant to a certificate of amendment to formally change its name from PeopleString Corporation to Vape Holdings, Inc. (the “Name Change”). The Company’s Board of Directors and shareholders representing approximately 53.3% of the outstanding shares of the Company’s common stock approved the Name Change by written consent on December 24, 2013.

	HIVE Ceramics Asset Purchase

	On February 28, 2014, the Company entered into an Asset Purchase Agreement (the “Agreement”) with HIVE Ceramics, LLC (“HIVE”) whereby the Company agreed to acquire all right, title and interest to the HIVE vaporization product and related intellectual property in exchange for the issuance of 500,000 shares of Series A Preferred Stock (“Series A Shares”) to HIVE. The Transaction formally closed on March 27, 2014; however, the Series A Shares had not yet been issued as of the period ended March 31, 2014.

	HIVE has been in development of a ceramic product line for use in the vaporization market. The development of this initial product line was completed in 2014. No sales of this product line were made prior to the acquisition of the HIVE product on March 27, 2014.

	The Company also received $250,000 in capital from HIVE at closing and, as a result, the Company issued a note payable to HIVE (the “HIVE Note”). The HIVE Note is dated March 27, 2014 payable to HIVE. In accordance with the Agreement, the Company issued the HIVE Note in exchange for the principal amount of $250,000. Per the terms of the HIVE Note, the maturity date is February 27, 2016 and the annual rate of interest is six percent (6%). No prepayment penalty exists. The HIVE Note is unsecured.

	Employment Agreements for Michael Cook as Director of Business Development and Kyle Tracey as Chief Executive Officer were also executed at Closing. Per Mr. Cook’s employment agreement, he is entitled to $80,000 per year in salary over a two (2) year employment term In the event that his employment is terminated without cause he will be entitled to payment of his base salary for a six (6) month period following termination. Per Mr. Tracey’s employment agreement, he is entitled to $120,000 per year in salary over a two (2) year employment term. In the event that his employment is terminated without cause he will be entitled to the remaining salary of the two (2) year employment term plus the issuance of five percent (5%) of the Company’s common stock on a fully diluted basis.

	During the three and six months ended March 31, 2014 and as of March 31, 2014, the Company accrued wages and taxes of $8,153 and $815 and for Mr. Cook and Mr. Tracey, respectively.

	BASIS OF PRESENTATION

	The accompanying unaudited interim financial statements have been prepared by the Company pursuant to the rules and regulations of the SEC. Certain information and disclosures normally included in the annual financial statements prepared in accordance with the accounting principles generally accepted in the United States of America have been condensed or omitted pursuant to such rules and regulations. In the opinion of management, all adjustments and disclosures necessary for a fair presentation of these financial statements have been included. Such adjustments consist of normal recurring adjustments.

	As a result of the merger between Vape and PeopleString, the Vape shareholders controlled the Company post-merger. This resulted in a change in reporting entity, whereby the historical financial statements of Vape are presented herein. The assets acquired and liabilities assumed were recorded at fair value; however, there were no significant assets acquired and approximately $24,000 in liabilities assumed.

	USE OF ESTIMATES

	The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates and assumptions include losses for warrant contingencies and the valuation of conversion features in notes.

	CONCENTRATION

	Credit Risk

	At times, the Company maintains cash balances at a financial institution in excess of the FDIC insurance limit. In addition, at we extend credit to customers in the normal course of business, after we evaluate the credit worthiness. The Company does not expect to take any unnecessary credit risks causing significant causing write-offs of potentially uncollectible accounts.

	REVENUE RECOGNITION

	The Company recognizes revenues from product sales when (a) persuasive evidence that an agreement exists; (b) the products have been delivered; (c) the prices are fixed and determinable and not subject to refund or adjustment; and (d) collection of the amounts due is reasonably assured.

	INVENTORY

	Inventory is valued at the lower of cost or market, as determined primarily by the average cost inventory method, and are stated using the first-in, first-out (FIFO) method. Management will record a provision for loss for obsolete or slow moving inventory to reduce carrying amounts to net realizable value.

	RESEARCH AND DEVELOPMENT

	Research and development costs are expensed as incurred. The costs of materials and equipment that will be acquired or constructed for research and development activities, and that have alternative future uses, both in research and development, marketing or sales, will be classified as property and equipment and depreciated over their estimated useful lives. To date, research and development costs include the research and development expenses related to prototypes of the Company’s products. During the three and six months ended March 31, 2014, research and development costs were $29,087 and $37,587, respectively.

	PER-SHARE INFORMATION

	Basic per-share information includes the weighted average shares outstanding during the periods. Dilutive per-share information includes shares available under convertible notes, options and warrants, to the extent these are not anti-dilutive. During the periods presented, 642,346 convertible note shares would have been included in the computation of dilutive shares outstanding since the exercise prices did not exceed the average market value of the Company's common stock if the Company generated net income. During the periods presented, no options and warrants would have been included had the Company generated net income in the computation of dilutive shares outstanding using the treasury-stock method since the exercise prices exceeded the average market value of the Company's common stock.

CONVERTIBLE DEBT

Convertible debt is accounted for under the guidelines established by Accounting Standards Codification (“ASC”) 470-20 “Debt with Conversion and Other Options”. ASC 470-20 governs the calculation of an embedded beneficial conversion, which is treated as an additional discount to the instruments where derivative accounting (explained below) does not apply. The amount of the value of warrants and beneficial conversion feature may reduce the carrying value of the instrument to zero, but no further. The discounts relating to the initial recording of the derivatives or beneficial conversion features are accreted over the term of the debt. Many of the conversion features embedded in the Company's convertible notes are variable and are adjusted based on a discount to market prices which could cause an unlimited number of common stock to be issued. The management and board of directors currently have the ability to authorize additional shares of common stock (See “NOTE 5 – CONVERTIBLE NOTES PAYABLE”).

When applicable, the Company calculates the fair value of warrants and conversion features issued with the convertible instruments using the Black-Scholes valuation method, using the same assumptions used for valuing employee options for purposes of ASC 718 “Compensation – Stock Compensation”, except that the contractual life of the warrant or conversion feature is used. Under these guidelines, the Company allocates the value of the proceeds received from a convertible debt transaction between the conversion feature and any other detachable instruments (such as warrants) on a relative fair value basis. The allocated fair value is recorded as a debt discount or premium and is amortized over the expected term of the convertible debt to interest expense. If the fair value exceeds the carrying value of the debt, an immediate charge to operations is recorded by management. Each reporting period, the Company will compute the estimated fair value of derivatives and record changes to operations.

The Company accounts for modifications of its BCF’s in accordance with ASC 470-50 “Modifications and Extinguishments.” ASC 470-50 requires the modification of a convertible debt instrument that changes the fair value of an embedded conversion feature and the subsequent recognition of interest expense or the associated debt instrument when the modification does not result in a debt extinguishment.

RECENT ACCOUNTING PRONOUNCEMENTS

The Financial Accounting Standards Board issues Accounting Standard Updates (“ASUs”) to amend the authoritative literature in Accounting Standards Codification (“ASC”). There have been a number of ASUs to date that amend the original text of ASC. The Company believes those issued to date either (i) provide supplemental guidance, (ii) are technical corrections, (iii) are not applicable to the Company or (iv) are not expected to have a significant impact on the Company.

Going_Concern

Going Concern	6 Months Ended
Going Concern	Mar. 31, 2014
Going Concern [Abstract]	'
GOING CONCERN	'
	NOTE 2. GOING CONCERN

	Vape’s financial statements reflect a net loss of $30,072,691, primarily due to a loss on settlement of warrants of $29,528,844, net cash used in operations of $252,270 and an accumulated deficit of $30,389,928. These matters raise substantial doubt about the ability of Vape to continue as a going concern. The management expects to obtain funding for the new operations for the foreseeable future; however, there are no assurances that the Company will obtain such funding. Vape’s financial statements do not include any adjustments to reflect the possible effects on recoverability and classification of assets or the amounts and classification of liabilities that may result from the inability to continue as a going concern.

Accrued_Expenses

Accrued Expenses	6 Months Ended
Accrued Expenses	Mar. 31, 2014
Accrued Expenses [Abstract]	'
ACCRUED EXPENSES	'
	NOTE 3. ACCRUED EXPENSES

	Accrued expenses at March 31, 2014 and September 30, 2013 were $20,051 and $7,573, respectively, primarily for accrued interest of $11,083 and $7,573, and accrued wages and taxes of $8,969 and $0, respectively.

Related_Party_Notes_Payable

Related Party Notes Payable	6 Months Ended
Related Party Notes Payable	Mar. 31, 2014
Related Party Transactions [Abstract]	'
RELATED PARTY NOTES PAYABLE	'
	NOTE 4. RELATED PARTY NOTES PAYABLE

	The Company had outstanding accounts payable balance to a related party (shareholder of the Company) in the amount of $15,000 as of September 30, 2013. This payable was converted into a note payable on December 7, 2013. The note payable bears interest of 6% per annum with a maturity date of December 1, 2016.

	On December 7, 2013, the Company issued a note payable to a shareholder of the Company in the amount of $23,462 for monies previously borrowed from shareholder. The note bears interest of 6% per annum and matures on December 1, 2016.

	On May 12, 2014, the Company issued a note payable to a related party of the Company in the amount of $40,000 for monies previously borrowed from the related party during the three and six months ended March 31, 2014. The note bears interest of 6% per annum and matures on May 1, 2016.

	See NOTE 1 regarding a $250,000 note payable to HIVE.

	During the six months ended March 31, 2014, the Company had recorded $885 of interest expense related to these notes, of which $885 was recorded as interest expense during the six months ended March 31, 2014.

	RELATED PARTY CONVERTIBLE NOTES PAYABLE

	On February 18, 2014, the Company issued an 8% Convertible Note to Kyle Tracey for monies borrowed from Mr. Tracey to cover outstanding accounts payable in the amount of $10,612 (the “Tracey Note”). Per the terms of the Tracey Note, the original principal balance is $10,612, and is not secured by any collateral or any assets pledged to the holder. The maturity date is February 18, 2016, and the annual rate of interest is eight percent (8%). Subject to certain limitations, the holder can, at its sole discretion, convert the outstanding and unpaid principal and interest into fully paid and nonassessable shares of the Company’s common stock. The conversion price for the Tracey Note is the lowest market closing price per share within the previous twenty (20) market days of the date of conversion minus a discount of forty percent (40%). We recorded a discount totaling $4,245 related to the beneficial conversion feature embedded in the notes upon issuance. We amortized $354 of the discount to interest expense during the three and six months ended March 31, 2014.

	On May 12, 2014, the Company issued an 8% Convertible Note to Kyle Tracey for monies borrowed from Mr. Tracey to cover outstanding accounts payable in the amount of $11,042 (the “Tracey Note II”). Per the terms of the Tracey Note II, the original principal balance is $11,042, and is not secured by any collateral or any assets pledged to the holder. The maturity date is May 12, 2016, and the annual rate of interest is eight percent (8%). Subject to certain limitations, the holder can, at its sole discretion, convert the outstanding and unpaid principal and interest into fully paid and nonassessable shares of the Company’s common stock. The conversion price for the Tracey Note II is the lowest market closing price per share within the previous twenty (20) market days of the date of conversion minus a discount of forty percent (40%).

	On May 12, 2014, the Company issued an 8% Convertible Note to its Director of Business Development, Michael Cook for monies borrowed from Mr. Cook to cover outstanding accounts payable in the amount of $11,825 (the “Cook Note”). Per the terms of the Cook Note, the original principal balance is $11,825, and is not secured by any collateral or any assets pledged to the holder. The maturity date is May 12, 2016, and the annual rate of interest is eight percent (8%). Subject to certain limitations, the holder can, at its sole discretion, convert the outstanding and unpaid principal and interest into fully paid and nonassessable shares of the Company’s common stock. The conversion price for the Cook Note is the lowest market closing price per share within the previous twenty (20) market days of the date of conversion minus a discount of forty percent (40%). These monies were funded to the Company during the three and six months ended March 31, 2014.

Convertible_Notes_Payable

Convertible Notes Payable	6 Months Ended
Convertible Notes Payable	Mar. 31, 2014
Debt Instruments [Abstract]	'
CONVERTIBLE NOTES PAYABLE	'
	NOTE 5. CONVERTIBLE NOTES PAYABLE

	On October 16, 2013, the Company issued an 8% Convertible Note to a shareholder (“8% Note I”), in exchange for $2,420 which the Company received on April 15, 2013. Per the terms of 8% Note I, the original principal balance is $2,420, and is not secured by any collateral or any assets pledged to the holder. The maturity date was April 15, 2015.Subject to certain limitations, the holder, at its sole discretion, could convert the outstanding and unpaid principal and interest into fully paid and nonassessable shares of the Company’s common stock. The conversion price for 8% Note I was the lowest market closing price per share within the previous twenty (20) market days of the date of conversion minus a discount of forty percent (40%). The note was converted on December 23, 2013 into 3,990 shares. We recorded a discount totaling $968 related to the beneficial conversion feature embedded in the note upon issuance. Such amount was fully accreted to interest expense during the three months ended December 31, 2013 due to the conversion, together with accrued interest of $150.

	On October 16, 2013, the Company issued an 8% Convertible Note to a shareholder (“8% Note II”), in exchange for $30,300 which the Company received on July 3, 2013. Per the terms of 8% Note II, the original principal balance was $30,300, and was not secured by any collateral or any assets pledged to the holder. The maturity was July 3, 2015. Subject to certain limitations, the holder, at its sole discretion, could convert the outstanding and unpaid principal and interest into fully paid and nonassessable shares of the Company’s common stock. The conversion price for 8% Note II was the lowest market closing price per share within the previous twenty (20) market days of the date of conversion minus a discount of forty percent (40%). The note was converted on December 23, 2013 into 49,139 shares of the Company’s common stock. We recorded a discount totaling $12,120 related to the beneficial conversion feature embedded in the note upon issuance. Such amount was fully accreted to interest expense during the three months ended December 31, 2013 due to the conversion, together with accrued interest of $ 1,239.


	On October 16, 2013, the Company issued an 8% Convertible Note to a shareholder (“8% Note III”) (collectively, the “8% Notes), in exchange for $180,940 which the Company received on March 5, 2013. Per the terms of 8% Note III, the original principal balance is $180,940, and is not secured by any collateral or any assets pledged to the holder. The maturity date is March 5, 2015, and the annual rate of interest is eight percent (8%). Subject to certain limitations, the holder can, at its sole discretion, convert the outstanding and unpaid principal and interest into fully paid and nonassessable shares of the Company’s common stock. The conversion price for 8% Note III is the lowest market closing price per share within the previous twenty (20) market days of the date of conversion minus a discount of forty percent (40%). We recorded a discount totaling $72,376 related to the beneficial conversion feature embedded in the note upon issuance. We amortized $12,772 and $25,544 of the discount to interest expense during the three and six months ended March 31, 2014.

	On January 31, 2014, the Company issued a 10% Convertible Note (the “10% Note”) to a third-party consultant (the “Holder”) in the principal amount of $100,000 for services rendered to the Company. The 10% Note is not secured by any collateral or any assets pledged to the Holder. The maturity date is January 31, 2015 and the annual rate of interest is ten percent (10%). Subject to certain limitations, the Holder can, at its sole discretion, convert the outstanding and unpaid principal and interest into fully paid and nonassessable shares of the Company’s common stock. The conversion price for the 10% Note is $2.00 per share. We recorded a discount totaling $84,375 related to the beneficial conversion feature embedded in the note upon issuance. We amortized $14,063 of the discount to interest expense during the three and six months ended March 31, 2014.

	Beginning on February 11, 2014, the Company issued 6% Convertible Notes (the “6% Notes”) pursuant to subscription agreements to ten (10) accredited investors (the “Holders”) with the aggregate principal amount of $270,000, of which $40,000 is from Kyle Tracey recorded as a related party convertible note payable. The 6% Notes are not secured by any collateral or any assets pledged to the Holders. The maturity dates are from February 28 2015 to March 31, 2015, and the annual rate of interest is six percent (6%). Subject to certain limitations, the Holders can, at their sole discretion, convert the outstanding and unpaid principal and interest of their notes into fully paid and nonassessable shares of the Company’s common stock. The conversion price of these 6% Notes is the average of the fifteen (15) lowest daily VWAP’s occurring during the twenty (20) consecutive trading days immediately preceding the date each Holder elects convert all of their 6% Note minus a discount of 40%. In no event will the conversion price be less than $3.00 per share or greater than $8.00 per share. The Company had a preexisting relationship with each of the Holders, and no general solicitation or advertising was used in connection with the issuance of the 6% Notes. We recorded a discount totaling $92,000 related to the beneficial conversion feature embedded in the notes upon issuance. We amortized $12,231 of the discount to interest expense during the three and six months ended March 31, 2014.

	On March 17, 2014, the Company issued an 8% Convertible Note to Jerome Kaiser, former CEO, CFO and Director of the Company for services rendered to the Company in the amount of $50,000 (the “Kaiser Note”) which was charged to expense during the three months March 31, 2014. Per the terms of the Kaiser Note, the principal balance is $50,000, and is not secured by any collateral or any assets pledged to the holders. The maturity date is March 17, 2015, and the annual rate of interest is eight percent (8%). Subject to certain limitations, the holder can, at his sole discretion, convert the outstanding and unpaid principal and interest into fully paid and nonassessable shares of the Company’s common stock. The conversion price for the Kaiser Note is the market closing price of the market day immediately preceding the date of conversion minus twenty percent (20%). We recorded a discount totaling $10,000 related to the beneficial conversion feature embedded in the notes upon issuance. We amortized $833 of the discount to interest expense during the three and six months ended March 31, 2014.

	On March 19, 2014, the Company issued an 8% Convertible Note to W-net Fund I, LP in exchange for the contribution of capital to the Company in the amount of $198,000 (the “W-net Note”). Per the terms of the W-net Note, the principal balance is $198,000, and is not secured by any collateral or any assets pledged to the holder. The maturity date is November 19, 2014 and interest accrues at 8% per annum. Subject to certain limitations, the holder can, at its sole discretion, convert the outstanding and unpaid principal and interest into fully paid and nonassessable shares of the Company’s common stock. The conversion price for the W-net Note is eighty percent (80%) of the average of the three (3) lowest daily closing bid prices (the 3 lowest prices will be calculated on a VWAP basis) occurring during the ten (10) consecutive Trading Days immediately preceding the applicable conversion date on which the holder elects to convert. In no event shall the conversion price be less than $5.50 or greater than $11.00. We recorded a discount totaling $158,400 related to the beneficial conversion feature embedded in the notes upon issuance. We amortized $19,800 of the discount to interest expense during the three and six months ended March 31, 2014.

	CONVERTIBLE NOTES PAYABLE, LONG-TERM
	On February 18, 2014, the Company issued 8% Convertible Notes to two third parties to cover outstanding accounts payable in the amount of $20,000. Per the terms of the notes, the aggregate principal balance is $20,000, and is not secured by any collateral or any assets pledged to the holders. The maturity date is February 18, 2016, and the annual rate of interest is eight percent (8%). Subject to certain limitations, the holders can, at their sole discretion, convert the outstanding and unpaid principal and interest into fully paid and nonassessable shares of the Company’s common stock. The conversion price for the notes is the lowest market closing price per share within the previous twenty (20) market days of the date of conversion minus a discount of forty percent (40%). We recorded a discount totaling $8,000 related to the beneficial conversion feature embedded in the notes upon issuance. We amortized $667 of the discount to interest expense during the three and six months ended March 31, 2014.

	The Company has the ability to increase the authorized common stock of the Company in the event that the convertible notes require more shares than available.

Anslow_Jaclin_LLP_Convertible_

Anslow & Jaclin, LLP Convertible Promissory Note	6 Months Ended
Anslow & Jaclin, LLP Convertible Promissory Note	Mar. 31, 2014
Anslow & Jaclin, LLP Convertible Promissory Note [Abstract]	'
ANSLOW & JACLIN, LLP CONVERTIBLE PROMISSORY NOTE	'
	NOTE 6. ANSLOW & JACLIN, LLP CONVERTIBLE PROMISSORY NOTE

	As of February 1, 2013, the Company had incurred certain debt owed to its former legal counsel, Anslow & Jaclin, LLP. In or about May 2013, this debt was sold to certain founding shareholders of the Private Company on a pro rata basis (the “A&J Debt”). The Company later issued a 6% Convertible Note documenting the convertible A&J Debt acquired by the founding shareholders of the Private Company (the “A&J Note”). Per the terms of the A&J Note, the original principal balance is $17,750, and is not secured by any collateral or any assets pledged to the holder. The maturity date is December 31, 2015, and the annual rate of interest is six percent (6%). Subject to certain limitations, a majority-in-interest of the shareholders can convert the outstanding and unpaid principal and interest into fully paid and nonassessable shares of the Company’s common stock. The conversion price for the A&J Note is $0.002 per share. Additionally, the Company shall have the right to call the conversion of the A&J Note upon completion of the merger transaction between the Private Company and Vape and an increase in the authorized common stock of Vape. We recorded a discount totaling $17,750 related to the beneficial conversion feature embedded in the note upon issuance.

	On December 24, 2013, the Company converted the entire principal and accrued interest of the A&J Note in the amount of $17,799 into 222,498 shares of the Company’s common stock at a per share conversion price of $0.002 issued on a pro rata basis to the shareholders of the Private Company. All fractional shares created by the conversion of the A&J Note were rounded to the nearest whole share. If the fraction created was one half or less, it was rounded down to the nearest whole share. If the fraction was more than one half, it was rounded up to the nearest whole share. Each shareholder received at least one share. We fully accreted the discount of $17,750 to interest expense during the three months ended December 31, 2013 due to the conversion, together with accrued interest of $1,592.

Commitments_And_Contingencies

Commitments And Contingencies	6 Months Ended
Commitments And Contingencies	Mar. 31, 2014
Commitments and Contingencies Disclosure [Abstract]	'
COMMITMENTS AND CONTINGENCIES	'
	NOTE 7. COMMITMENTS AND CONTINGENCIES

	On or about April 4, 2014, Cranshire Capital, LP, a private investment fund with its principal place of business in Northbrook, Illinois (“Cranshire”), filed a lawsuit against the Company. Cranshire alleged that it was a holder of various warrants to purchase common stock ("Warrant Shares") issued by the Company back in May 2011, and that by reason of certain equity issuances made by the Company during 2013, the exercise and conversion prices in Cranshire’s warrants should have been reset. Specifically, Cranshire alleged that the Warrants contained “full ratchet anti-dilution provisions” whereby certain “subsequent equity sales” made by the Company at any time after 2011 below the exercise price on the warrants resulted in Cranshire’s exercise price adjusting down to the same price at which the equity was issued. In addition, a corresponding increase in the Warrant Shares issuable resulted from the adjustment to maintain the aggregate value of the warrants.

	On April 16, 2014, the Company, entered into separate settlement agreements with Cranshire and another warrant holder, Iroquois Master Fund, Ltd. (“Iroquois”). Pursuant to the settlement agreements, the Company agreed to issue an aggregate of 583,427 shares of the Company’s common stock to the settling holders upon partial exercise of their warrant positions pursuant to exercise notices previously submitted by them. An additional 337,626 Warrant Shares remain outstanding and may be exercised by the settling holders in the future at their election. The Company and the settling holders provided mutual general releases. In connection with the settlements, Cranshire agreed to dismiss with prejudice its action filed on April 4, 2014 against the Company.

	The settlement agreements also provide for certain selling restrictions on the settling holders. Each holder separately agreed with the Company that (i) on any trading day on which the aggregate dollar volume of the common stock on the principal exchange on which the common stock of the company is then traded is less than $1,000,000, the holders shall not sell a number of warrant shares that exceeds 15% of the daily trading volume of the common stock on such trading day as measured on the principal exchange on which such common stock is then traded and (ii) on any trading day on which the aggregate dollar volume of the common stock on the principal exchange on which the common stock of the Company is then traded is greater than or equal to $1,000,000, the holders shall not sell a number of warrant shares that exceeds 20% of the daily trading volume of the common stock on such trading day as measured on the principal exchange on which such common stock is then traded. In addition, the settlement agreements contain what is commonly referred to as “most favored nation” provisions whereby the settling holders are entitled to the benefit of more favorable terms if any future agreements are entered into with similar warrant holders on more favorable terms.

	Upon learning of the settlements with Cranshire and Iroquois, the Warberg WF I, LP and related entities (collectively, the “Warberg Entities”) disputed their original exercise which resulted in 3,542 shares issued to them.

	On April 22, 2014, the Company entered into a settlement agreement with the Warberg Entities. Pursuant to the settlement agreement, the Company agreed to issue an aggregate of 356,415 shares of the Company’s common stock in the aggregate to the settling holders upon partial exercise of their warrant positions pursuant to exercise notices previously submitted by them. An additional 378,855 Warrant Shares remained outstanding to be exercised by the settling holders in the future at their election. Warrants Shares of 3,992,800 were cancelled as a result of the settlement.

	The Company and the Warberg Entities provided mutual general releases and the settlement agreement with the Warberg Entities included identical selling restrictions to the Cranshire and Iroquois settlements.

	On April 24, 2014, the Company entered into a settlement agreement with Sphinx Trading, LP (“Sphinx”). Pursuant to the settlement agreement, the Company agreed to issue an aggregate of 481,569 shares of the Company’s common stock to the settling holder upon partial exercise of its warrants pursuant to exercise notices previously submitted by it. An additional 100 Warrant Shares remain outstanding and may be exercised by the settling holder in the future at its election. Warrants Shares of 9,559 were cancelled as a result of the settlement.

	The Company and Sphinx provided mutual general releases and the settlement agreement with Sphinx included identical selling restrictions and most favored nations provisions as provided in the Cranshire and Iroquois settlements.

	On April 24, 2014, Cranshire was issued an additional 262,523 shares of common stock of the Company pursuant to a notice of exercise of their outstanding, but unissued Warrants as set forth in its settlement agreement with the Company. Following this exercise Cranshire has 2,000 Warrants outstanding. Warrants Shares of 5,211 were cancelled as a result of the settlement.

	On April 28, 2014, the Warberg Entities were issued an additional 368,903 shares of common stock of the Company pursuant to a notice of exercise in full of their outstanding, but unissued Warrants as set forth in their settlement agreement with the Company. Following this exercise, the Warberg Entities had zero Warrants outstanding. Warrants Shares of 9,952 were cancelled as a result of the settlement.

	On May 14, 2014, Cranshire was issued an additional 99,538 shares of common stock of the Company pursuant to a notice of exercise of a warrant that was assigned to Cranshire from an unsettled Warrant holder. Warrants Shares of 3,620 were cancelled as a result of the settlement.

	As a result of the settlements, the exercise price of the Warrants decreased from $28.00 per share to $0.114 per share and the Warrants outstanding increased from 34,200 to 8,400,000. As of the time of this filing, the Company has issued 2,152,375 Warrant Shares to its warrant holders at $0.114 per share and cancelled 4,021,142 Warrants via settlement and/or cashless exercise. An additional 2,226,483 Warrants remain outstanding and unexercised.

	The Company recorded the full settlement liability as of March 31, 2014 for the Warrant Shares issued and the Warrants that remain outstanding and unexercised that would be entitled to the same settlement. We believe the issuance of convertible notes in the three months ended March 31, 2014 triggered the full ratchet anti-dilution adjustment; before the provision was triggered, the fair value of the warrant liability was not significant as the exercise was so far out of the money. As a result of the above settlements with warrant holders, the Company recorded a loss on settlement of warrants of $29,528,844 during the three and six months ended March 31, 2014 and a long-term warrant liability of $29,430,022 as of March 31, 2014 based on 4,407,200 shares of common stock under the settlement at the Company’s closing stock prices of $4.72 to $7.25 per share on the settlement dates discussed above.

Stockholders_Deficit

Stockholders' Deficit

6 Months Ended

Mar. 31, 2014

Stockholders' Deficit [Abstract]

STOCKHOLDERS' DEFICIT

NOTE 8. STOCKHOLDERS’ DEFICIT

COMMON STOCK

On November 27, 2013, the board of directors and shareholders approved an increase in the authorized number of shares of common and preferred stock which may be issued by the Company to 1,000,000,000 shares and 100,000,000 shares, respectively. On December 3, 2013, the certificate of amendment was filed with the Secretary of State of Delaware.

REVERSE STOCK SPLIT

On December 24, 2013, the Company’s Board and a majority of its shareholders approved a one for forty (1:40) reverse stock split of the Company’s common stock (the “Reverse Stock Split”). The Reverse Stock Split became effective on January 8, 2014. As a result of the Reverse Stock Split, all share information has been retroactively adjusted for all periods presented. All fractional shares created by the Reverse Stock Split were rounded to the nearest whole share. If the fraction created was one half or less, it was rounded down to the nearest whole share. If the fraction was more than one half, it was rounded up to the nearest whole share. Each shareholder received at least one share. The number of the Company’s authorized shares of common stock did not change in connection with the Reverse Stock Split.

PREFERRED STOCK

On April 1, 2014, the Board formally approved the filing of a Preferred Stock Designation in connection with the commitment of 500,000 Series A Shares to HIVE on March 27, 2014 pursuant to its authority to issue blank check preferred stock as provided in the Company’s Certificate of Incorporation. Per the Certificate of Designation (the “Designation”), there are 100,000,000 shares of preferred stock authorized by the Company’s Certificate of Incorporation. The Company is authorized to issue 500,000 shares of Series A Shares pursuant to the Designation. As provided in the Designation (and as set forth in the HIVE Asset Purchase Agreement), Series A Shares are entitled to vote at a 15-1 ratio to Common Stock. Each share of preferred stock shall initially be convertible into one share of common stock (500,000 shares of common stock in the aggregate). On the two year anniversary of the transaction of HIVE, the preferred stock conversion ratio shall be adjusted as follows: a one-time pro rata adjustment of up to ten-for-one (10-1) based upon the Company generating aggregate gross revenues over the two years of at least $8,000,000 (e.g. If the Company generates only $4,000,000 in aggregate gross revenues over the two year period then the convertible ratio will adjust to 5-1). In no event will the issuance convert into more than 5,000,000 shares of common stock of the Company.

The value ascribed to the Series A Shares was based on the historical costs of the assets acquired on March 27, 2014 from HIVE since the transfer of assets was made among entities under common control.

CONTRIBUTED SERVICES

During the period from Inception to March 31, 2014, services were provided by the Company’s Chief Executive Officer at no cost. The Company has recorded $5,000 per month for the services prior to commencing significant operations. The fair value of contributed services were based on previously negotiated monthly salary and has been recognized in the statement of stockholders’ deficit as contributed services, and the accompanying statements of operations as general and administrative expenses.

WARRANTS

Before the settlements described above in NOTE 7, on March 26, 2014 and March 31, 2014, respectively, the Warberg Entities exercised a total of 19,250 Series A Warrants (the “Warrants”) issued in May 2011 at $28.00 exercise price per share. In connection with this exercise, the Company issued 3,542 shares to the Warberg Entities via cashless exercise as provided in the Warrants.

OPTIONS

Option activity during the six months ended March 31, 2014, was as follows:

Weighted

Aggregate

Average

Intrinsic

Exercise

Remaining

Value

Price

Contractual Term

Options outstanding at September 30, 2013

125,000

13.2

2.3

Options granted

Options exercised

Options cancelled/forfeited/expired

Options outstanding at March 31, 2014

125,000

13.2

1.9

Options exercisable at March 31, 2014

125,000

13.2

1.9

The aggregate intrinsic value in the table above represents the total pre-tax intrinsic value (the aggregate difference between the closing stock prices of Vape’s common stock at the specified dates and the exercise prices for in-the-money options) that would have been received by the option holders if all in-the-money options had been exercised on the specified dates.

There were no options granted, forfeited or exercised during the six months ended March 31, 2014. There were no options cancelled during the six months ended March 31, 2014. The Company did not record any stock-based option compensation during the six months ended March 31, 2014.

The fair value of each option award is estimated on the date of grant using the Black-Scholes valuation model, consistent with the provisions of ASC 718. Because option-pricing models require the use of subjective assumptions, changes in these assumptions can materially affect the fair value of the options. Vape has limited relevant historical information to support the expected exercise behavior because no exercises have taken place.

Intellectual_Property

Intellectual Property	6 Months Ended
Intellectual Property	Mar. 31, 2014
Intellectual Property [Abstract]	'
INTELLECTUAL PROPERTY	'
	NOTE 9. INTELLECTUAL PROPERTY

	The Company plans to rely on a combination of trademark, copyright, trade secret and patent laws in the United States as well as confidentiality procedures and contractual provisions to protect future proprietary technology and its brands, as they are developed. The Company has begun to execute on this plan with the acquisition of the patent pending HIVE Ceramic vaporization product and the HIVE trademark as well as several pending trademark applications. The Company intends to continue to create or acquire proprietary vaporizers and e-cigarettes, and various trademarks, patents and/or copyrights for brands which are developed.

	TRADEMARKS

	On March 27, 2014, the Company and Stone Arch Studio, LLC entered into a Trademark Assignment Agreement whereby the Company acquired all right, title, priority and interest to the “HIVE” trademark U.S. Registration No. 44513069 as registered with the U.S. Patent and Trade Office (“USPTO”). This acquisition further protects the Company’s HIVE Ceramics brand vaporization line.

	In addition, the Company has filed for trademark protection with the USPTO on several additional trademarks and tradenames to be utilized by the Company in the future as the marks register.

	PATENTS

	On March 27, 2014, the Company formally closed its acquisition of the patent pending HIVE Ceramics vaporization technology. The Company has already begun exploiting this technology and intends to prosecute the patent application to completion.

	The Company also has been in discussions to acquire additional patented technology from third parties to further grow and develop its branded product lines in the vaporization market.

Subsequent_Events

Subsequent Events	6 Months Ended
Subsequent Events	Mar. 31, 2014
Subsequent Events [Abstract]	'
SUBSEQUENT EVENTS	'
	NOTE 10. SUBSEQUENT EVENTS

	On May 12, 2014, the Board, by unanimous written consent, elected to amend the conversion prices of the following Notes: 1) the 6% Notes and 2) the W-net Notes by adjusting the “floor” and “ceiling” on their conversion prices to $1.00/$3.00 from $3.00/$8.00 and $5.50/$11.00 respectively due to recent unexpected circumstances (including the exercise of numerous warrants pursuant to a full ratchet anti-dilution adjustment issued by previous management of the Corporation back in 2011) to better reflect the current market and maintain relationships with its noteholders.

	RELATED PARTY NOTES PAYABLE

	On May 12, 2014, the Company issued a note payable to a related party of the Company in the amount of $40,000 for monies previously borrowed from the related party during the three and six months ended March 31, 2014. The note bears interest of 6% per annum and matures on May 1, 2016.

	RELATED PARTY CONVERTIBLE NOTES PAYABLE

	On May 12, 2014, the Company issued an 8% Convertible Note to Kyle Tracey for monies borrowed from Mr. Tracey to cover outstanding accounts payable in the amount of $11,042 (the “Tracey Note II”). Per the terms of the Tracey Note II, the original principal balance is $11,042, and is not secured by any collateral or any assets pledged to the holder. The maturity date is May 12, 2016, and the annual rate of interest is eight percent (8%). Subject to certain limitations, the holder can, at its sole discretion, convert the outstanding and unpaid principal and interest into fully paid and nonassessable shares of the Company’s common stock. The conversion price for the Tracey Note II is the lowest market closing price per share within the previous twenty (20) market days of the date of conversion minus a discount of forty percent (40%).

	On May 12, 2014, the Company issued an 8% Convertible Note to its Director of Business Development, Michael Cook for monies borrowed from Mr. Cook to cover outstanding accounts payable in the amount of $11,825 (the “Cook Note”). Per the terms of the Cook Note, the original principal balance is $11,825, and is not secured by any collateral or any assets pledged to the holder. The maturity date is May 12, 2016, and the annual rate of interest is eight percent (8%). Subject to certain limitations, the holder can, at its sole discretion, convert the outstanding and unpaid principal and interest into fully paid and nonassessable shares of the Company’s common stock. The conversion price for the Cook Note is the lowest market closing price per share within the previous twenty (20) market days of the date of conversion minus a discount of forty percent (40%). These monies were funded to the Company during the three and six months ended March 31, 2014.

	TERMINATION OF LETTER OF INTENT FOR JOINT VENTURE WITH GROWLIFE, INC.

	On May 14, 2014, the Company and GrowLife, Inc., a Delaware corporation (“GrowLife”) mutually agreed to terminate their non-binding letter of intent (“LOI”) entered into on or about March 17, 2014 for a joint venture into the research and development of patentable technology to create pharmaceutical grade extractions from cannabis (the “Joint Venture”). The Joint Venture was originally announced pursuant to a press release issued jointly by the companies on March 17, 2014.

Description_of_Business_and_Su

Description of Business and Summary of Significant Accounting Policies (Policies)	6 Months Ended
	Mar. 31, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'
BUSINESS	'
	BUSINESS

	Vape Holdings, Inc. (formerly PeopleString Corporation) (“Vape,” the “Company,” “we,” “us,” “our,” “our company”) is a holding company with its primary focus in the manufacturing and distribution of healthy and sustainable vaporization products. The Company has designed and recently began marketing and distributing vaporization products under a unique brand. The Company has introduced a nonporous, non-corrosive, chemically inert ceramic vaporization element as a healthy, sustainable alternative to traditional titanium and quartz vaporization materials, as well as lower-grade ceramic found in traditional electronic cigarettes and vaporizers. This material can be used for a wide range of applications, including stand-alone vaporization products and "E-cigs." Electronic cigarettes come in a variety of designs ranging from those that look vastly like traditional cigarettes, to larger vaporizer units which are capable of vaporizing liquid with varying viscosity. The process of vaporization is believed to eliminate the smoke, tar, ash, and other byproducts of traditional smoking by utilizing lower temperatures in a controlled electronic environment.

	HIVE Ceramics is the premier brand under the Vape umbrella, bringing to market a medical and food grade ceramic that has countless design and product crossover capabilities in existing and emerging markets.

	The Company intends to rely on a combination of trademark, copyright, trade secret and patent laws in the United States as well as confidentiality procedures and contractual provisions to protect future proprietary technology and its brands, as they are developed. The Company has created or acquired and continues in the process of creating and/or acquiring proprietary vaporizers and e-cigarettes, and various trademarks, patents and copyrights for brands which are developed or in development. The Company is actively engaged in improving and expanding lines of branded products through business alliances and acquisitions, as well as developing its branded retail business expansion. Vape and its business units are organized and directed to operate strictly in accordance with all applicable state and federal laws.
RECENT ACQUISITIONS	'
	RECENT ACQUISITIONS

	On September 30, 2013, the then PeopleString Corporation, and its wholly-owned subsidiary, RewardString Corporation (“RewardString”), and Vape Holdings, Inc., a Nevada corporation (the “Private Company”) formed on March 26, 2013, closed a Merger and Reorganization Agreement whereby the Private Company merged with RewardString, with the Private Company being the surviving entity (the “Merger”). The Private Company shareholders represented approximately 74.95% of the total issued and outstanding common stock of the merged company.
	The merger among PeopleString, RewardString and the Private Company was accounted for as a reverse acquisition and change in reporting entity, whereby the Private Company was the accounting acquirer. The Merger was accounted for using the purchase method of accounting in accordance with ASC 805 Business Combinations, whereby the estimated purchase was allocated to tangible net assets acquired based upon preliminary fair values at the date of acquisition. Accordingly, the assets and liabilities of PeopleString and RewardString were recorded at fair value; the assets of PeopleString and RewardString were not significant. The historical results of operations and cash flows of the Private Company were reported since its inception on March 26, 2013 (“Inception”). On September 30, 2013, the Company approved a change in fiscal year end of the Company from December 31st to September 30th due to a change in reporting entity. Following such change, the date of the Company’s next fiscal year end is September 30, 2014.

	Vape commenced revenue generating operations and exited the development stage late in the three month period ended March 31, 2014. There was no significant activity during the prior period from March 26, 2013 to March 31, 2013 and thus, such periods are not presented.

	Effective as of January 8, 2014, the Company amended its Certificate of Incorporation with the Delaware Secretary of State pursuant to a certificate of amendment to formally change its name from PeopleString Corporation to Vape Holdings, Inc. (the “Name Change”). The Company’s Board of Directors and shareholders representing approximately 53.3% of the outstanding shares of the Company’s common stock approved the Name Change by written consent on December 24, 2013.

	HIVE Ceramics Asset Purchase

	On February 28, 2014, the Company entered into an Asset Purchase Agreement (the “Agreement”) with HIVE Ceramics, LLC (“HIVE”) whereby the Company agreed to acquire all right, title and interest to the HIVE vaporization product and related intellectual property in exchange for the issuance of 500,000 shares of Series A Preferred Stock (“Series A Shares”) to HIVE. The Transaction formally closed on March 27, 2014; however, the Series A Shares had not yet been issued as of the period ended March 31, 2014.

	HIVE has been in development of a ceramic product line for use in the vaporization market. The development of this initial product line was completed in 2014. No sales of this product line were made prior to the acquisition of the HIVE product on March 27, 2014.

	The Company also received $250,000 in capital from HIVE at closing and, as a result, the Company issued a note payable to HIVE (the “HIVE Note”). The HIVE Note is dated March 27, 2014 payable to HIVE. In accordance with the Agreement, the Company issued the HIVE Note in exchange for the principal amount of $250,000. Per the terms of the HIVE Note, the maturity date is February 27, 2016 and the annual rate of interest is six percent (6%). No prepayment penalty exists. The HIVE Note is unsecured.

	Employment Agreements for Michael Cook as Director of Business Development and Kyle Tracey as Chief Executive Officer were also executed at Closing. Per Mr. Cook’s employment agreement, he is entitled to $80,000 per year in salary over a two (2) year employment term In the event that his employment is terminated without cause he will be entitled to payment of his base salary for a six (6) month period following termination. Per Mr. Tracey’s employment agreement, he is entitled to $120,000 per year in salary over a two (2) year employment term. In the event that his employment is terminated without cause he will be entitled to the remaining salary of the two (2) year employment term plus the issuance of five percent (5%) of the Company’s common stock on a fully diluted basis.

	During the three and six months ended March 31, 2014 and as of March 31, 2014, the Company accrued wages and taxes of $8,153 and $815 and for Mr. Cook and Mr. Tracey, respectively.
BASIS OF PRESENTATION	'
	BASIS OF PRESENTATION

	The accompanying unaudited interim financial statements have been prepared by the Company pursuant to the rules and regulations of the SEC. Certain information and disclosures normally included in the annual financial statements prepared in accordance with the accounting principles generally accepted in the United States of America have been condensed or omitted pursuant to such rules and regulations. In the opinion of management, all adjustments and disclosures necessary for a fair presentation of these financial statements have been included. Such adjustments consist of normal recurring adjustments.

	As a result of the merger between Vape and PeopleString, the Vape shareholders controlled the Company post-merger. This resulted in a change in reporting entity, whereby the historical financial statements of Vape are presented herein. The assets acquired and liabilities assumed were recorded at fair value; however, there were no significant assets acquired and approximately $24,000 in liabilities assumed.
USE OF ESTIMATES	'
	USE OF ESTIMATES

	The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates and assumptions include losses for warrant contingencies and the valuation of conversion features in notes.
CONCENTRATION	'
	CONCENTRATION

	Credit Risk

	At times, the Company maintains cash balances at a financial institution in excess of the FDIC insurance limit. In addition, at we extend credit to customers in the normal course of business, after we evaluate the credit worthiness. The Company does not expect to take any unnecessary credit risks causing significant causing write-offs of potentially uncollectible accounts.
REVENUE RECOGNITION	'
	REVENUE RECOGNITION

	The Company recognizes revenues from product sales when (a) persuasive evidence that an agreement exists; (b) the products have been delivered; (c) the prices are fixed and determinable and not subject to refund or adjustment; and (d) collection of the amounts due is reasonably assured.
INVENTORY	'
	INVENTORY

	Inventory is valued at the lower of cost or market, as determined primarily by the average cost inventory method, and are stated using the first-in, first-out (FIFO) method. Management will record a provision for loss for obsolete or slow moving inventory to reduce carrying amounts to net realizable value.
RESEARCH AND DEVELOPMENT	'
	RESEARCH AND DEVELOPMENT

	Research and development costs are expensed as incurred. The costs of materials and equipment that will be acquired or constructed for research and development activities, and that have alternative future uses, both in research and development, marketing or sales, will be classified as property and equipment and depreciated over their estimated useful lives. To date, research and development costs include the research and development expenses related to prototypes of the Company’s products. During the three and six months ended March 31, 2014, research and development costs were $29,087 and $37,587, respectively.
PER-SHARE INFORMATION	'
	PER-SHARE INFORMATION

	Basic per-share information includes the weighted average shares outstanding during the periods. Dilutive per-share information includes shares available under convertible notes, options and warrants, to the extent these are not anti-dilutive. During the periods presented, 642,346 convertible note shares would have been included in the computation of dilutive shares outstanding since the exercise prices did not exceed the average market value of the Company's common stock if the Company generated net income. During the periods presented, no options and warrants would have been included had the Company generated net income in the computation of dilutive shares outstanding using the treasury-stock method since the exercise prices exceeded the average market value of the Company's common stock.
CONVERTIBLE DEBT	'
	CONVERTIBLE DEBT

	Convertible debt is accounted for under the guidelines established by Accounting Standards Codification (“ASC”) 470-20 “Debt with Conversion and Other Options”. ASC 470-20 governs the calculation of an embedded beneficial conversion, which is treated as an additional discount to the instruments where derivative accounting (explained below) does not apply. The amount of the value of warrants and beneficial conversion feature may reduce the carrying value of the instrument to zero, but no further. The discounts relating to the initial recording of the derivatives or beneficial conversion features are accreted over the term of the debt. Many of the conversion features embedded in the Company's convertible notes are variable and are adjusted based on a discount to market prices which could cause an unlimited number of common stock to be issued. The management and board of directors currently have the ability to authorize additional shares of common stock (See “NOTE 5 – CONVERTIBLE NOTES PAYABLE”).

	When applicable, the Company calculates the fair value of warrants and conversion features issued with the convertible instruments using the Black-Scholes valuation method, using the same assumptions used for valuing employee options for purposes of ASC 718 “Compensation – Stock Compensation”, except that the contractual life of the warrant or conversion feature is used. Under these guidelines, the Company allocates the value of the proceeds received from a convertible debt transaction between the conversion feature and any other detachable instruments (such as warrants) on a relative fair value basis. The allocated fair value is recorded as a debt discount or premium and is amortized over the expected term of the convertible debt to interest expense. If the fair value exceeds the carrying value of the debt, an immediate charge to operations is recorded by management. Each reporting period, the Company will compute the estimated fair value of derivatives and record changes to operations.

	The Company accounts for modifications of its BCF’s in accordance with ASC 470-50 “Modifications and Extinguishments.” ASC 470-50 requires the modification of a convertible debt instrument that changes the fair value of an embedded conversion feature and the subsequent recognition of interest expense or the associated debt instrument when the modification does not result in a debt extinguishment.
RECENT ACCOUNTING PRONOUNCEMENTS	'
	RECENT ACCOUNTING PRONOUNCEMENTS

	The Financial Accounting Standards Board issues Accounting Standard Updates (“ASUs”) to amend the authoritative literature in Accounting Standards Codification (“ASC”). There have been a number of ASUs to date that amend the original text of ASC. The Company believes those issued to date either (i) provide supplemental guidance, (ii) are technical corrections, (iii) are not applicable to the Company or (iv) are not expected to have a significant impact on the Company.

Stockholders_Deficit_Tables

Stockholders' Deficit (Tables)	6 Months Ended
Stockholders' Deficit (Tables)	Mar. 31, 2014
Stockholders' Deficit [Abstract]	'
Schedule of option activity	'
		Shares		Weighted			Weighted		Aggregate
				Average			Average		Intrinsic
				Exercise			Remaining		Value
				Price			Contractual Term
	Options outstanding at September 30, 2013		125,000		$	13.2		2.3		$	-
	Options granted		-		$	-
	Options exercised		-		$	-
	Options cancelled/forfeited/expired		-		$	-
	Options outstanding at March 31, 2014		125,000		$	13.2		1.9		$	-
	Options exercisable at March 31, 2014		125,000		$	13.2		1.9		$	-

Description_of_Business_and_Su1

Description of Business and Summary of Significant Accounting Policies (Details) (USD $)	3 Months Ended	6 Months Ended	0 Months Ended	6 Months Ended				0 Months Ended
	Mar. 31, 2014	Mar. 31, 2014	Dec. 24, 2013	Mar. 31, 2014	Mar. 31, 2014	Mar. 31, 2014	Sep. 30, 2013	Feb. 28, 2014
	Mar. 31, 2014	Mar. 31, 2014	Board Of Directors And Shareholders [Member]	Per Mr Cooks [Member]	Per Mr Traceys [Member]	Hive Ceramics [Member]	Merger And Reorganization Agreement [Member]	Asset Purchase Agreement [Member]
Description Of Business And Summary Of Significant Accounting Policies Textual [Abstract]	'	'	'	'	'	'	'	'
Business mergers and acquistion, Description	'	'	'	'	'	'	'On September 30, 2013, the then PeopleString Corporation, and its wholly-owned subsidiary, RewardString Corporation ("RewardString"), and Vape Holdings, Inc., a Nevada corporation (the "Private Company") formed on March 26, 2013, closed a Merger and Reorganization Agreement thereby the Private Company merged with RewardString, with the Private Company being the surviving entity (the "Merger").	'
Percentage of common shares issued to Vape shareholders out of total issued and outstanding of merged company	'	'	'	'	'	'	74.95%	'
Percentage of common stock outstanding representing by the Board of Directors and shareholders	'	'	53.30%	'	'	'	'	'
Liabilities assumed	'	$24,000	'	'	'	'	'	'
Shares issued during period	'	'	'	'	'	'	'	500,000
Capital from HIVE Ceramics	'	'	'	'	'	250,000	'	'
Principal amount	'	'	'	'	'	250,000	'	'
Debt Instrument, Maturity Date	'	1-May-16	'	'	'	27-Feb-16	'	'
Debt Instrument, Interest Rate, Stated Percentage	'	'	'	'	'	6.00%	'	'
Compensation	'	'	'	80,000	120,000	'	'	'
Employment Term	'	'	'	'2 years	'2 years	'	'	'
Employment Agreement Description	'	'In the event that his employment is terminated without cause he will be entitled to the remaining salary of the two (2) year employment term plus the issuance of five percent (5%) of the Company's common stock on a fully diluted basis.	'	'	'	'	'	'
Accrued wages and taxes payable	8,153	815	'	'	'	'	'	'
Research and development expense	29,087	37,587	'	'	'	'	'	'
Dilutive shares outstanding using treasury stock	'	$642,346	'	'	'	'	'	'

Going_Concern_Details

Going Concern (Details) (USD $)	3 Months Ended	6 Months Ended
Going Concern (Details) (USD $)	Mar. 31, 2014	Mar. 31, 2014	Sep. 30, 2013
Going Concern (Textual)	'	'	'
Net income (loss)	($29,805,364)	($30,072,691)	'
Net cash used in operating activities	'	-252,270	'
Accumulated deficit	-30,389,928	-30,389,928	-317,237
Loss on settlement of stock	($29,528,844)	($29,528,844)	'

Accrued_Expenses_Details

Accrued Expenses (Details) (USD $)	Mar. 31, 2014	Sep. 30, 2013
Accrued Expenses (Textual)	'	'
Accrued expenses	$20,051	$7,573
Accrued interest	11,083	7,573
Accrued wages and taxes	$8,969	$0

Related_Party_Notes_Payable_De

Related Party Notes Payable (Details) (USD $)	6 Months Ended		0 Months Ended		3 Months Ended		1 Months Ended	3 Months Ended
	Mar. 31, 2014	Sep. 30, 2013	Dec. 07, 2013	Sep. 30, 2013	12-May-14	12-May-14	Feb. 18, 2014	12-May-14
			Shareholder [Member]	Shareholder [Member]	Related Party [Member]	Michael Cook [Member]	Kyle Tracey [Member]	Kyle Tracey Two [Member]
						8% Convertible Note [Member]	8% Convertible Note [Member]	8% Convertible Note [Member]
Due To Related Parties (Textual)	'	'	'	'	'	'	'	'
Accounts payable, related parties	'	'	'	$15,000	$40,000	$11,825	$10,612	$11,042
Interest rate	'	'	6.00%	6.00%	6.00%	8.00%	8.00%	8.00%
Debt instrument, maturity date	1-May-16	'	1-Dec-16	'	1-May-16	12-May-16	18-Feb-16	12-May-16
Notes payable, related parties	340,287	'	23,462	'	'	'	'	'
Short-term Debt, Average Outstanding Amount	'	'	'	'	'	11,825	10,612	11,042
Conversion description	'	'	'	'	'	'The conversion price for the Cook Note is the lowest market closing price per share within the previous twenty (20) market days of the date of conversion minus a discount of forty percent (40%).	'The conversion price for the Tracey Note is the lowest market closing price per share within the previous twenty (20) market days of the date of conversion minus a discount of forty percent (40%).	'The conversion price for the Tracey Note II is the lowest market closing price per share within the previous twenty (20) market days of the date of conversion minus a discount of forty percent (40%).
Notes payable	250,000	'	'	'	'	'	'	'
Interest expense related to notes payable	885	'	'	'	'	'	'	'
Interest expense	885	'	'	'	'	'	'	'
Discount on debt	'	'	'	'	'	'	4,245	'
Amortized discount to interest expense	'	'	'	'	'	'	$354	'

Convertible_Notes_Payable_Deta

Convertible Notes Payable (Details) (USD $)

6 Months Ended

9 Months Ended

0 Months Ended

1 Months Ended

0 Months Ended

1 Months Ended

0 Months Ended

6 Months Ended

1 Months Ended

0 Months Ended

6 Months Ended

0 Months Ended

3 Months Ended

6 Months Ended

0 Months Ended

Mar. 31, 2014

Dec. 31, 2013

Sep. 30, 2013

Mar. 19, 2014

Feb. 18, 2014

Mar. 19, 2014

Mar. 17, 2014

Dec. 23, 2013

Oct. 16, 2013

Mar. 31, 2014

Dec. 23, 2013

Oct. 16, 2013

Mar. 31, 2014

Oct. 16, 2013

Mar. 31, 2014

Jan. 31, 2014

Feb. 11, 2014

8% Convertible Note [Member]

8% Note I [Member]

8% Note II [Member]

8% Note III [Member]

10% Convertible Note [Member]

6% Convertible Notes [Member]

Maximum [Member]

Minimum [Member]

Jerome Kaiser [Member]

Third Party Consultant [Member]

investors

Maximum [Member]

Minimum [Member]

Convertible Notes (Textual)

Convertible note

$121,336

$198,000

$20,000

$50,000

$40,000

Principal amount

198,000

20,000

50,000

2,420

30,300

180,940

100,000

270,000

Maturity date

1-May-16

19-Nov-14

18-Feb-16

17-Mar-15

15-Apr-15

3-Jul-15

5-Mar-15

31-Jan-15

31-Mar-15

28-Feb-15

Convertible price, description

'A one-time pro rata adjustment of up to ten-for-one (10-1) based upon the Company generating aggregate gross revenues over the two years of at least $8,000,000 (e.g. If the Company generates only $4,000,000 in aggregate gross revenues over the two year period then the convertible ratio will adjust to 5-1). In no event will the issuance convert into more than 5,000,000 shares of common stock of the Company.

'The conversion price for the W-net Note is eighty percent (80%) of the average of the three (3) lowest daily closing bid prices (the 3 lowest prices will be calculated on a VWAP basis) occurring during the ten (10) consecutive Trading Days immediately preceding the applicable conversion date on which the holder elects to convert.

'The conversion price for the notes is the lowest market closing price per share within the previous twenty (20) market days of the date of conversion minus a discount of forty percent (40%).

'The conversion price for the Kaiser Note is the market closing price of the market day immediately preceding the date of conversion minus twenty percent (20%).

'The conversion price for 8% Note I was the lowest market closing price per share within the previous twenty (20) market days of the date of conversion minus a discount of forty percent (40%).

'The conversion price for 8% Note II was the lowest market closing price per share within the previous twenty (20) market days of the date of conversion minus a discount of forty percent (40%).

'The conversion price for 8% Note III was the lowest market closing price per share within the previous twenty (20) market days of the date of conversion minus a discount of forty percent (40%).

'The conversion price of these 6% Notes is the average of the fifteen (15) lowest daily VWAPs occurring during the twenty (20) consecutive trading days immediately preceding the date each Holder elects convert all of their 6% Note minus a discount of 40%.

Common stock issued on conversion

3,990

49,139

Interest expense

885

150

1,239

12,772

25,544

Discount related to beneficial conversion feature

72,376

968

12,120

72,376

Interest rate

8.00%

10.00%

6.00%

Conversion price

$11

$5.50

Amortized discount to interest expense

19,800

667

833

14,063

12,231

Discount on debt

$158,400

$8,000

$10,000

$84,375

$92,000

Number of investors

Anslow_Jaclin_LLP_Convertible_1

Anslow & Jaclin, LLP Convertible Promissory Note (Details) (USD $)	6 Months Ended	9 Months Ended	0 Months Ended		6 Months Ended
	Mar. 31, 2014	Dec. 31, 2013	Dec. 24, 2013	Feb. 15, 2013	Mar. 31, 2014	Feb. 01, 2013
	Mar. 31, 2014	Dec. 31, 2013	A & J Note [Member]	A & J Note [Member]	A & J Note [Member]	A & J Note [Member]
Anslow & Jaclin, LP Convertible Promissory Note (Textual)	'	'	'	'	'	'
Principle amount	'	'	$17,799	$17,750	'	'
Conversion price	'	'	$0.00	'	'	$0.00
Annual rate of interest	'	'	'	'	'	6.00%
Conversion shares	'	'	222,498	'	'	'
Maturity date	1-May-16	'	'	31-Dec-15	'	'
Discount related to beneficial conversion feature	$72,376	$72,376	'	'	$17,750	'

Commitments_And_Contingencies_

Commitments And Contingencies (Details Textuals) (USD $)

3 Months Ended

0 Months Ended

3 Months Ended

6 Months Ended

1 Months Ended

0 Months Ended

1 Months Ended

0 Months Ended

Mar. 31, 2014

Apr. 28, 2014

Apr. 16, 2014

Mar. 31, 2014

Apr. 22, 2014

Apr. 28, 2014

14-May-14

Apr. 24, 2014

Apr. 16, 2014

Apr. 24, 2014

Apr. 28, 2014

Apr. 16, 2014

Apr. 28, 2014

Apr. 16, 2014

Warberg WF I, LP

Subsequent Event [Member]

Warrants [Member]

Warberg WF I, LP

Iroquois Master Fund, Ltd

Minimum [Member]

Maximum [Member]

Subsequent Event [Member]

Warberg WF I, LP

Cranshire Capital, LP

Iroquois Master Fund, Ltd

Sphinx Trading, LP

Minimum [Member]

Maximum [Member]

Warberg WF I, LP

Iroquois Master Fund, Ltd

Warberg WF I, LP

Iroquois Master Fund, Ltd

Commitments and Contingencies [Line Items]

Warrants issued

19,250

2,152,375

Exercise price per share

0.114

Shares issued during period

3,542

583,427

356,415

3,542

481,569

Warrants outstanding

337,626

378,855

2,000

100

34,200

8,400,000

Principal exchange of common stock

$1,000,000

Number of warrants perecentage

15.00%

20.00%

Warrants cancelled

9,952

3,992,800

4,021,142

3,620

5,211

9,559

Warrant unissued

368,903

99,538

262,523

Warrants outstanding and unexercised

2,226,483

Loss on settlement of stock

29,528,844

Long term warrant liability

$29,430,022

Closing stock shares

4,407,200

Shares issued, price per share

$4.72

$7.25

Stockholders_Deficit_Details

Stockholders' Deficit (Details) (Stock Options [Member], USD $)	6 Months Ended
	Mar. 31, 2014
Stock Options [Member]	'
STOCK OPTIONS/WARRANTS:	'
Options/ Warrants outstanding, Shares, Beginning balance	125,000
Options/ Warrants granted	'
Option/ Warrants Exercised	'
Cancelled/forfeited/expired	'
Options/ Warrants Outstanding, Shares, Ending Balance	125,000
Options/ Warrants exercisable, Shares	125,000
Option/ Warrents Weighted Average Exercise Price, Beginning balance	$13.20
Option/ Warrents Granted, Weighted Average Exercise Price	'
Option/ Warrents Exercised, Weighted Average Exercise Price	'
Option/ Warrents Cancelled/forfeited/expired, Weighted Average Exercise Price	'
Option/ Warrents Weighted Average Exercise Price, Ending Balance	$13.20
Options/ Warrants exercisable, Weighted Average Exercise Price	$13.20
Options/ Warrants outstanding, Weighted Average Remaining Contractual Term, Beginning	'2 years 3 months 18 days
Options/ Warrants outstanding, Weighted Average Remaining Contractual Term, Ending	'1 year 10 months 24 days
Options/ Warrants exercisable, Weighted Average Remaining Contractual Term	'1 year 10 months 24 days
Option/ Warrents Outstanding, Aggregate Intrinsic Value, Beginning balance	'
Option/ Warrents Outstanding, Aggregate Intrinsic value, Balance	'
Options/ Warrants exercisable, Aggregate Intrinsic value	'

Stockholders_Deficit_Details_T

Stockholders' Deficit (Details Textual) (USD $)	6 Months Ended			6 Months Ended		3 Months Ended	0 Months Ended
	Mar. 31, 2014	Nov. 27, 2013	Sep. 30, 2013	Mar. 31, 2014	Mar. 31, 2014	Mar. 31, 2014	Dec. 24, 2013
	Mar. 31, 2014	Nov. 27, 2013	Sep. 30, 2013	Series A Preferred Stock [Member]	Preferred Stock [Member]	Warberg WF I, LP	Board Of Directors And Shareholders [Member]
Stockholders' Deficit (Textual)	'	'	'	'	'	'	'
Contributed services rendered	($102,000)	'	'	'	'	'	'
Shares issued during period	'	'	'	500,000	'	3,542	'
Common stock, shares authorized	1,000,000,000	1,000,000,000	1,000,000,000	'	'	'	'
Preferred stock, Shares authorized	100,000,000	100,000,000	100,000,000	500,000	100,000,000	'	'
Description of asset purchase agreement	'	'	'	'	'Series A Shares are entitled to vote at a 15-1 ratio to Common Stock and are convertible on a maximum 10 for one basis into Common Stock	'	'
Reverse stock split, Description	'	'	'	'	'	'	'On December 24, 2013, the Company's Board and a majority of its shareholders approved a one for forty (1:40) reverse stock split of the Company's common stock (the "Reverse Stock Split"). The Reverse Stock Split became effective on January 8, 2014. As a result of the Reverse Stock Split, all share information has been retroactively adjusted for all periods presented. All fractional shares created by the Reverse Stock Split were rounded to the nearest whole share.
Convertible price, description	'A one-time pro rata adjustment of up to ten-for-one (10-1) based upon the Company generating aggregate gross revenues over the two years of at least $8,000,000 (e.g. If the Company generates only $4,000,000 in aggregate gross revenues over the two year period then the convertible ratio will adjust to 5-1). In no event will the issuance convert into more than 5,000,000 shares of common stock of the Company.	'	'	'	'	'	'
Warrants issued	'	'	'	'	'	19,250	'
Exercise price per share	'	'	'	'	'	28	'

Subsequent_Events_Details

Subsequent Events (Details) (USD $)	6 Months Ended	3 Months Ended		3 Months Ended
	Mar. 31, 2014	12-May-14	Mar. 31, 2014	12-May-14	12-May-14	12-May-14	12-May-14
		Subsequent Events [Member]	Subsequent Events [Member]	Subsequent Events [Member]	Subsequent Events [Member]	Subsequent Events [Member]	Subsequent Events [Member]
				Director of Business Development [Member]	8% Convertible Note [Member]	Floor [Member]	Ceiling [Member]
						6% Convertible Note [Member]	6% Convertible Note [Member]
Subsequent Events (Textual)	'	'	'	'	'	'	'
Conversion description	'	'	'	'The conversion price for the Cook Note is the lowest market closing price per share within the previous twenty (20) market days of the date of conversion minus a discount of forty percent (40%).	'The conversion price for the Tracey Note II is the lowest market closing price per share within the previous twenty (20) market days of the date of conversion minus a discount of forty percent (40%).	'Conversion prices to $1.00/$3.00 from $3.00/$8.00 and $5.50/$11.00 respectively.	'Conversion prices to $1.00/$3.00 from $3.00/$8.00 and $5.50/$11.00 respectively.
Principal amount	'	'	$40,000	$11,825	$11,042	'	'
Interest rate	'	'	6.00%	8.00%	8.00%	'	'
Maturity date	1-May-16	1-May-16	'	12-May-16	12-May-16	'	'